These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1008 related articles for article (PubMed ID: 33306607)

  • 1. Successful Treatment With Bortezomib for Refractory and Complicated Acquired Thrombotic Thrombocytopenic Purpura in an Adolescent Girl.
    Azapağasi E; Uysal Yazici M; Eroğlu N; Albayrak M; Kucur Ö; Fettah A
    J Pediatr Hematol Oncol; 2021 May; 43(4):e587-e591. PubMed ID: 33306607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura.
    Eskazan AE
    Ann Hematol; 2016 Oct; 95(11):1751-6. PubMed ID: 27590601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib.
    van Balen T; Schreuder MF; de Jong H; van de Kar NC
    Eur J Haematol; 2014 Jan; 92(1):80-2. PubMed ID: 24118335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic thrombocytopenic purpura.
    Joly BS; Coppo P; Veyradier A
    Blood; 2017 May; 129(21):2836-2846. PubMed ID: 28416507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of thrombotic thrombocytopenic purpura].
    Galstyan GM; Maschan AA; Klebanova EE; Kalinina II
    Ter Arkh; 2021 Jun; 93(6):736-745. PubMed ID: 36286842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.
    Patriquin CJ; Thomas MR; Dutt T; McGuckin S; Blombery PA; Cranfield T; Westwood JP; Scully M
    Br J Haematol; 2016 Jun; 173(5):779-85. PubMed ID: 27009919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
    Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
    Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
    Coppo P; Froissart A;
    Hematology Am Soc Hematol Educ Program; 2015; 2015():637-43. PubMed ID: 26637782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory acquired thrombotic thrombocytopenic purpura in a patient with sickle cell trait successfully treated with caplacizumab.
    Aggarwal V; Singer Z; Ledingham D; Othman I
    Hematology; 2021 Dec; 26(1):590-593. PubMed ID: 34396933
    [No Abstract]   [Full Text] [Related]  

  • 10. Relapsed/refractory thrombotic thrombocytopenic purpura treated with N-acetylcysteine: a case report.
    Demircioğlu S; Ekinci Ö; Doğan A; Demir C
    Scott Med J; 2018 Nov; 63(4):122-124. PubMed ID: 29739267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe, refractory and rapidly evolving thrombotic thrombocytopenic purpura.
    Acedillo RR; Govind M; Kashgary A; Clark WF
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27284100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
    Ma W; Bai W; Wu X; Zhao J; Li M; Zeng X
    Lupus; 2020 Dec; 29(14):1961-1967. PubMed ID: 32838618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of relapsing autoimmune thrombotic thrombocytopenic purpura with rituximab.
    Sankararaman S; Jeroudi M; Ibrahim H
    Pediatr Int; 2014 Dec; 56(6):914-918. PubMed ID: 25521977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I treat refractory thrombotic thrombocytopenic purpura.
    Sayani FA; Abrams CS
    Blood; 2015 Jun; 125(25):3860-7. PubMed ID: 25784681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib in relapsed/refractory immune thrombotic thrombocytopenic purpura: A single-centre retrospective cohort and systematic literature review.
    Lee NCJ; Yates S; Rambally S; Sarode R; Ibrahim IF; Shen YM; Hofmann SL; Bavli NR
    Br J Haematol; 2024 Feb; 204(2):638-643. PubMed ID: 37571963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic thrombocytopenic purpura during pregnancy refractory to plasma exchange and rituximab].
    Kaneda Y; Kitagawa J; Yamaguchi K; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kanemura N; Kasahara S; Hara T; Shimizu M; Tsurumi H
    Rinsho Ketsueki; 2019; 60(3):209-212. PubMed ID: 31068517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab-refractory thrombotic thrombocytopenic purpura responsive to intravenous but not subcutaneous bortezomib.
    Patel PP; Becker J; Freyer C; Griffiths E; Thompson JE; Wang ES
    Transfusion; 2016 Apr; 56(4):970-4. PubMed ID: 26779871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Refractory thrombotic thrombocytopenic purpura achieving complete remission with rituximab treatment].
    Iino H; Ogawa Y; Yanagisawa K; Shimizu H; Mitsui T; Ishizaki T; Hayakawa M; Matsumoto M; Nojima Y; Handa H
    Rinsho Ketsueki; 2017; 58(3):204-209. PubMed ID: 28381686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S
    Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agents.
    Gómez-De León A; Villela-Martínez LM; Yáñez-Reyes JM; Gómez-Almaguer D
    Expert Rev Hematol; 2020 May; 13(5):461-470. PubMed ID: 32243196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 51.